IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1

CUSIP: 46333XAD0

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Debt / DBCV 2.250% 6/1
Market price (% of par)
133.99%
Total 13F principal
$338,036,000
Principal change
+$791,000
Total reported market value
$454,348,199
Number of holders
32
Value change
+$1,624,126
Number of buys
12
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 46333XAD0?
CUSIP 46333XAD0 identifies 46333XAD0 - IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 as of Q2 2017

As of 30 Jun 2017, IRONWOOD PHARMACEUTICALS INC - DBCV 2.250% 6/1 was held by 32 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $338,036,000 in principal (par value) of the bond. The largest 10 bondholders included LINDEN ADVISORS LP, CITADEL ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, Calamos Advisors LLC, UBS ASSET MANAGEMENT AMERICAS INC, OAKTREE CAPITAL MANAGEMENT LP, Allianz Asset Management GmbH, PRICE T ROWE ASSOCIATES INC /MD/, CSS LLC/IL, and Polar Asset Management Partners Inc.. This page lists 32 institutional bondholders reporting positions for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.